Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
45 hedge funds and large institutions have $84.4M invested in Augmedix, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 24 closing their positions.
168% more capital invested
Capital invested by funds: $31.5M → $84.4M (+$52.9M)
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
13% less funds holding
Funds holding: 52 → 45 (-7)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$9.07M |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
+$2.52M |
| 3 |
TC
Trium Capital
London,
United Kingdom
|
+$2.39M |
| 4 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$2.04M |
| 5 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$1.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Samjo Management
New York
|
-$5.82M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.63M |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.25M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.11M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.1M |
AUGX Hedge Fund Activity: Q3 2024 in Review
45 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q3 2024, worth a combined $84.4M — up 168% from $31.5M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of AUGX and 17 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 13 added.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $9.07M. The largest seller was Samjo Management, cutting an estimated $5.82M.
- 45 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q3 2024, down from 52 in Q2 2024.
- Funds reported $84.4M of Augmedix, Inc. Common Stock stock for Q3 2024, up 168% quarter-over-quarter.
- 17 funds opened new Augmedix, Inc. Common Stock positions in Q3 2024 and 24 closed out, a net change of -7 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q3 2024 was Beryl Capital Management, an estimated $9.07M added.
- The largest Augmedix, Inc. Common Stock seller in Q3 2024 was Samjo Management, an estimated $5.82M sold.
Based on aggregated 13F filings for Q3 2024.